A patient of acute leukemia with Sweet's syndrome who developed heart failure after receiving 107 mg/㎡ daunorubicin was reported. There seemed to be genetic factors of individuals in inducing anthracycline cardiotoxicity. Further study on genetic analysis of such a disease will be necessary for clarification of the genetic factors susceptible to anthracyclines.